NCT06529237
- Conditions
- Falciparum Malaria, Infections, Malaria, +6 more
- Locations
-
- Centro de Investigaçao em Saúde de Manhiça Manhiça, Maputo Province, Mozambique
Clinical trial condition
Protozoan Infections
Explore clinical trials studying Protozoan Infections. Study availability and eligibility vary by location and protocol.
1,495 public trials
89 recruiting studies
Protozoan Infections trial results
NCT06514560
- Conditions
- Cutaneous Leishmaniases, Euglenozoa Infections, Infections, +9 more
- Locations
-
- Africa Leprosy, Tuberculosis, Rehabilitation and Training (ALERT) Hospital Addis Ababa, Ethiopia
Recruiting
Dexamethasone for Cerebral Toxoplasmosis
NCT04341155
- Conditions
- Abscess, Brain Abscess, Brain Diseases, +12 more
- Locations
-
- Hasan Sadikin General Hospital Bandung, West Java, Indonesia
NCT06307171
- Conditions
- Euglenozoa Infections, Infections, Leishmaniasis, +7 more
- Locations
-
- IRCCS Sacro Cuore Don Calabria hospital Negrar, Verona, Italy
NCT05602610
- Conditions
- Disease Attributes, Euglenozoa Infections, Infections, +13 more
- Locations
-
- University of Gondar Gonder, Ethiopia
NCT05285735
- Conditions
- Infections, Malaria, Mosquito-Borne Diseases, +4 more
- Locations
-
- 4C Pharma Solutions Piscataway, New Jersey, United States
NCT04897516
- Conditions
- Chagas Disease, Euglenozoa Infections, Infections, +4 more
- Locations
-
- Instituto Nacional de Parasitología "Dr. Mario Fatala Chaben" Buenos Aires, Argentina
- Fundación Huésped Buenos Aires, Argentina
- Hospital Francisco Javier Muñiz Buenos Aires, Argentina
- Hospital Donación Francisco Santojanni Buenos Aires, Argentina
NCT04020536
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Brucelloses, +17 more
- Locations
-
- Huashan Hospital of Fudan University Shanghai, Shanghai Municipality, China
Recruiting
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
NCT00004317
- Conditions
- Coccidiosis, Communicable Diseases, Disease Attributes, +8 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
Not yet recruiting
Safety and Immunogenicity of the Recombinant Malaria Vaccines in Healthy Adults Aged 18-50 Years
NCT07831226
- Conditions
- Infections, Malaria, Malaria Vaccine, +6 more
- Locations
-
- Nucleus Network Pty Ltd. Melbourne, Australia